EpiBone
Keith Yeager serves as the Chief Technology Officer and Co-founder of Link Biosystems Inc since August 2021. In addition, Keith has maintained a role as a Research Engineer at Columbia University in the City of New York since April 2006, contributing to platform development for microphysiological systems and various research projects. As a Co-founder and Engineer at Nasal Medical LTD, Keith focuses on developing innovative respiratory health products, while also holding a similar position at EpiBone, Inc., where efforts are directed at creating automated systems for bone construct culture. Keith previously worked as an Adjunct Professor at The Cooper Union and as a Research Engineer at the Lab for Minimally Invasive Surgery at NYU/HJD. Keith holds a Master of Engineering degree from The Cooper Union for the Advancement of Science and Art.
This person is not in any teams
This person is not in any offices
EpiBone
3 followers
EpiBone is a revolutionary bone reconstruction company that allows patients to “grow their own bone”. EpiBone’s pioneering technology utilizes a scan of the patient’s bone defect and the patient’s own stem cells to construct and cultivate a defect-specific autologous-like bone graft. EpiBone is strategically positioned to provide a superior bone graft that will provide exact defect repair, a simplified surgical procedure, improved bone formation and regeneration, and shorter recovery times, without the complications of foreign body implantation, to the over 900,000 patients who undergo bone-related surgeries each year.